ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Now There’s a Painless Cure for the Most Common Cancer Type

By: NewsUSA

(NewsUSA) - The scorching sun is the major reason that skin cancer is the nation’s most common cancer type. But there’s seriously good news -- dermatologists can now cure most cases of nonmelanoma skin cancer (basal cell and squamous cell carcinomas) without scalpels, pain, bleeding, infection, surgical scarring or the need for reconstructive surgery.     

Dermatologists around the country are rapidly adopting FDA-cleared, image-guided, superficial radiotherapy (SRT) as a patient-friendly treatment alternative to traditional Mohs surgery for common skin cancers.   

The contrast in these treatments, both of which generate cure rates above 99 percent, is startling. Century-old Mohs surgery involves the repeated cutting away of diseased tissue until skin samples viewed under a microscope show that only healthy tissue remains.     

With newer image-guided SRT, a patient visits the doctor for a few 15-minute sessions per week over several weeks. Each time, the doctor uses an ultrasound imaging device that lets them view a live image that distinguishes cancerous tissue from healthy tissue. Using those images, the doctor aims low-level x-rays at the treatment site, damaging and killing the cancer cells. The patient can see the tumor shrinking until it’s entirely gone. The procedure is painless, and there are no surgical scars to mark where the treatment took place. More than 500 dermatologists offer it, and that number is growing fast.     

Ruby Wepler, an 86-year-old, life long tennis player in Stow, Ohio, had Mohs surgery on her face three years ago. “It was very scary. You go into the office and they numb your face, cut that particular area and check to see if they got it all. And then you have to come back again and they go a little deeper if they didn't get it all. It was painful,” she says.     

“I was diagnosed again last year,” Ruby continues, “with cancer on my cheek and they suggested image-guided SRT. What surprised me was that it took no time at all. They went out of the room, pushed the button and a minute later they come back and it's all over. After a series of treatments, the cancer is gone and there's no scarring at all.”     

Surveys show a 99.9-percent patient satisfaction rate with image-guided SRT, which is covered by Medicare and most insurance plans.     

For more information and to learn where image-guided SRT is available, visit GentleCure.com.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  233.22
+4.06 (1.77%)
AAPL  278.85
+1.30 (0.47%)
AMD  217.43
+3.19 (1.49%)
BAC  53.65
+0.66 (1.25%)
GOOG  320.12
-0.16 (-0.05%)
META  647.95
+14.34 (2.26%)
MSFT  491.92
+6.42 (1.32%)
NVDA  176.98
-3.28 (-1.82%)
ORCL  201.95
-3.01 (-1.47%)
TSLA  430.17
+3.59 (0.84%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.